Lumibird SA

Paris Stock Exchange LBIRD.PA

Lumibird SA Return on Equity (ROE) for the year ending December 31, 2023: 3.69%

Lumibird SA Return on Equity (ROE) is 3.69% for the year ending December 31, 2023, a -37.19% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Lumibird SA Return on Equity (ROE) for the year ending December 31, 2022 was 5.87%, a -23.21% change year over year.
Lumibird SA Return on Equity (ROE) for the year ending December 31, 2021 was 7.64%, a 122.42% change year over year.
Lumibird SA Return on Equity (ROE) for the year ending December 31, 2020 was 3.44%, a -51.32% change year over year.
Lumibird SA Return on Equity (ROE) for the year ending December 31, 2019 was 7.06%, a -20.64% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

Paris Stock Exchange: LBIRD.PA

Lumibird SA

CEO	Dr. Marc Le Flohic
IPO Date	April 12, 2000
Location	France
Headquarters	2 rue Paul Sabatier
Employees	1,053
Sector	Technology
Industries 3D Printing Biotechnology Defense & Military Drones Eyewear Hardware & Electronics Medical Instruments Robotics

Description

Lumibird SA designs, manufactures, and sells various lasers for the scientific, industrial, and medical applications worldwide. It operates in two divisions, Photonics and Medical. The Photonics division offers solid-state lasers, high power laser diodes, fiber lasers, fiber amplifiers and components, photonics solutions for time-of-flight lidar and range-finding, and doppler lidar systems for wind measurement. Its products are used in various applications, such as industrial and scientific, defense and space, and lidar sensors. The Medical division provides medical and ophthalmological solutions from diagnosis to laser treatment. The company was founded in 1970 and is headquartered in Lannion, France.

Key trends

Past 5 years